|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03240510 |
|
Date of registration:
|
28/07/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience
|
|
Scientific title:
|
Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience |
|
Date of first enrolment:
|
January 1, 2014 |
|
Target sample size:
|
150 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03240510 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Tunisia
| | | | | | | |
|
Contacts
|
|
Name:
|
Ilhem Bettaieb, Dr |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Salah Azaïz Cancer Institute |
|
|
Name:
|
Syrine Abdeljaoued, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Salah Azaïz Cancer Institute |
|
|
Name:
|
Amor Gamoudi, Pr |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Salah Azaïz Cancer Institute |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Histological diagnosis of male breast cancer
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Male Breast Cancer
|
|
Primary Outcome(s)
|
|
Clinico-biological characteristics of the disease
[Time Frame: Through study completion, an average of 4 year]
|
|
Clinical outcomes
[Time Frame: Through study completion, an average of 4 year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|